Study: New Prostate Cancer Test Could Avoid Unnecessary Biopsies
A urine test could have avoided one-third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study.
Read MorePosted by Melanie Hamilton-Basich | Feb 26, 2021 | Prostate, Urinalysis & Toxicology |
A urine test could have avoided one-third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study.
Read MorePosted by Melanie Hamilton-Basich | Feb 25, 2021 | Prenatal Testing |
The method uses a DNA biomarker to easily screen pregnant women for harmful prenatal environmental contaminants like air pollution linked to childhood illness and developmental disorders.
Read MorePosted by Laurie Bonner | Feb 24, 2021 | Cancer, Molecular Diagnostics |
Rapid adoption of molecular testing in cancer necessitates quality cell line-derived controls.
Read MorePosted by Laurie Bonner | Feb 17, 2021 | Covid 19, Molecular Diagnostics |
The TaqPath Covid-19, Flu A, Flu B Combo Kit is a real-time PCR test for the detection and differentiation of RNA from the SARS-CoV2, influenza A, and influenza B viruses in nasopharyngeal and nasal swabs.
Read MorePosted by Melanie Hamilton-Basich | Feb 16, 2021 | Prostate |
The Prolaris test can more accurately predict the aggressiveness of prostate cancer allowing for more precise treatment and avoidance of more intense therapies with a patient’s parallel morbidities.
Read More